Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine Heart Disease.

Deepak R. Talreja1, Gregory W. Barsness

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. barsness.gregory@mayo.edu

Current Treatment Options in Cardiovascular Medicine
|February 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy.

Current interventional cardiology reports·2001
Same author

Improving Endothelial Function with ACE Inhibitors: An Important Therapeutic Target After Coronary Interventions.

Current interventional cardiology reports·2001
Same author

Enhanced External Counterpulsation in Unrevascularizable Patients.

Current interventional cardiology reports·2001
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Diabetes and thyroid disease significantly worsen cardiovascular outcomes, necessitating integrated endocrine and cardiac care. Proper management requires addressing metabolic disturbances and screening for thyroid dysfunction in heart patients.

Area of Science:

  • Endocrinology and Cardiology
  • Metabolic disorders and cardiovascular health

Background:

  • Rising rates of obesity and diabetes mellitus contribute to a cardiovascular disease epidemic.
  • Diabetic patients exhibit poorer prognoses for chronic coronary artery disease and acute coronary syndromes.
  • Thyroid disease is a common endocrine disorder impacting cardiovascular patient function.

Purpose of the Study:

  • To highlight the critical intersection of endocrine and cardiovascular diseases.
  • To emphasize the need for integrated management strategies for patients with both conditions.
  • To underscore the importance of recognizing endocrine disorders presenting with cardiovascular manifestations.

Main Methods:

  • Review of existing literature on diabetes, thyroid disease, and cardiovascular outcomes.

Related Experiment Videos

  • Analysis of therapeutic strategies for cardiovascular disease in diabetic versus non-diabetic patients.
  • Discussion of diagnostic approaches, including thyroid-stimulating hormone screening for cardiac patients.

    • Main Results:

    • Diabetes is associated with significantly worse cardiovascular prognosis.
    • Management of cardiovascular disease in diabetics must address metabolic disturbances.
    • Screening for thyroid dysfunction is recommended for patients with coronary artery disease or arrhythmias.

    Conclusions:

    • Integrated understanding of endocrine and cardiac systems is crucial for optimal patient care.
    • Endocrine disorders frequently present with cardiovascular symptoms, requiring careful evaluation.
    • Tailored management considering metabolic and endocrine status improves cardiovascular outcomes.